Link to agenda
https://www.ninds.nih.gov/About-NIN...DS-Advisory-Council-Agenda-September-4-5-2019
The meeting is actually 2 days long but the 5 September session is closed (not webcast).
Relevant session for ME is scheduled to begin at 1:20pm (ET)
AGENDA
September 4, 2019
OPEN SESSION
12:30 p.m.
I. Call to Order and Opening Remarks
Dr. Walter Koroshetz, Chairperson, Director, NINDS
12:35 p.m.
II. Report of the Director, Division of Extramural Activities, NINDS
Dr. Robert Finkelstein
A. Consideration of Minutes of May 23-24, Meeting
B. Confirmation of Dates for Future Council Meetings
Wed. & Thurs., February 5-6, 2020
Wed. & Thurs., May 27-28, 2020
Wed. & Thurs., September 9-10, 2020
Wed. & Thurs., February 10-11, 2021
Wed. & Thurs., May 26-27, 2021
Wed. & Thurs., September 8-9, 2021
C. Other Items
Expedited Review Process
Extramural Announcements
12:45 p.m.
III. Report of the Director, NINDS
Dr. Walter Koroshetz
1:05 p.m.
IV. Discussion of Director’s Report
1:20 p.m.
V. ME/CFS Working Group Report to Council
Dr. Andrew Breeden, Health Program Specialist, NINDS
Dr. Steven Roberds, Chief Scientific Officer, Tuberous Sclerosis Alliance
2:05 p.m.
VI. 2019 ADRD Summit Report
Dr. Rod Corriveau, Program Director, NINDS
Dr. Julie Schneider, The Deborah R. And Edgar D. Jannotta Presidential Professor of Pathology and Neurological Sciences,
Associate Director, Rush Alzheimer's Disease Center, Rush University Medical Center
2:45 p.m.
BREAK
3:00 p.m.
VII. Update from the Scientific Director of Intramural Research
Dr. Lorna Role, Scientific Director, NINDS
4:00 p.m.
VIII. NINDS Early Stage Investigator Analysis
Dr. William Daley, Health Program Specialist, NINDS
4:30 p.m.
IX. Initiatives Requiring Concept Clearance
6:00 p.m. **
ADJOURNMENT
September 5, 2019
8:30 a.m.
CLOSED SESSION
This portion of the meeting is being closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5, U.S. Code and Section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2).
X. Review of Conflict of Interest, Confidentiality, and Council Procedures
Council Consideration of Pending Applications
Dr. Robert Finkelstein, Executive Secretary, NANDS Council
This portion of the meeting is being closed to the public in accordance with the provisions set forth in sections 552b(c)(6), Title 5, U.S. Code and Section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2).
XI. Review of the Division of Intramural Research Board of Scientific Counselors' Reports
Dr. Walter Koroshetz
1:00 p.m. **
ADJOURNMENT
** This time is tentative